Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey C Farrell

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Hepatology Communications|June 7, 2019
Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic SteatohepatitisGeorge N Ioannou, Charles S Landis, Ga-Young Jin, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediatorJun Yu, Emilia Ip, Aileen Dela Peña, et al.
Journal of Clinical and Translational Research|March 16, 2019
Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-κB or Akt/mTORC1Evi Arfianti, Claire Z Larter, Seungsoo Lee, et al.
Journal of Hepatology|February 19, 2008
Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathwaysClaire Z Larter, Matthew M Yeh, W Geoffrey Haigh, et al.
Journal of Gastroenterology and Hepatology|February 10, 2018
Mouse models of non-alcoholic steatohepatitis: A reflection on recent literatureFahrettin Haczeyni, Matthew M Yeh, George N Ioannou, et al.
Gastroenterology|August 8, 2007
Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in miceNarci C Teoh, Yoshiya Ito, Jacqueline Field, et al.
Journal of Hepatology|March 19, 2013
Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndromeDerrick M Van Rooyen, Lay T Gan, Matthew M Yeh, et al.
The American Journal of Gastroenterology|June 24, 2003
Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progressionShirley A Coverdale, Dev A Samarasinghe, Rita Lin, et al.
Gastroenterology|June 28, 2011
Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitisDerrick M Van Rooyen, Claire Z Larter, W Geoffrey Haigh, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability indexArchana Sud, Jason M Hui, Geoffrey C Farrell, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Hepatology Communications|June 7, 2019
Cholesterol Crystals in Hepatocyte Lipid Droplets Are Strongly Associated With Human Nonalcoholic SteatohepatitisGeorge N Ioannou, Charles S Landis, Ga-Young Jin, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediatorJun Yu, Emilia Ip, Aileen Dela Peña, et al.
Journal of Clinical and Translational Research|March 16, 2019
Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-κB or Akt/mTORC1Evi Arfianti, Claire Z Larter, Seungsoo Lee, et al.
Journal of Hepatology|February 19, 2008
Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathwaysClaire Z Larter, Matthew M Yeh, W Geoffrey Haigh, et al.
Journal of Gastroenterology and Hepatology|February 10, 2018
Mouse models of non-alcoholic steatohepatitis: A reflection on recent literatureFahrettin Haczeyni, Matthew M Yeh, George N Ioannou, et al.
Gastroenterology|August 8, 2007
Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in miceNarci C Teoh, Yoshiya Ito, Jacqueline Field, et al.
Journal of Hepatology|March 19, 2013
Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndromeDerrick M Van Rooyen, Lay T Gan, Matthew M Yeh, et al.
The American Journal of Gastroenterology|June 24, 2003
Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progressionShirley A Coverdale, Dev A Samarasinghe, Rita Lin, et al.
Gastroenterology|June 28, 2011
Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitisDerrick M Van Rooyen, Claire Z Larter, W Geoffrey Haigh, et al.
Hepatology (Baltimore, Md.)|May 4, 2004
Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability indexArchana Sud, Jason M Hui, Geoffrey C Farrell, et al.
Pageof 13